Open AccessStatins: have we found the Holy Grail?
Author(s) -
Raban Jeger,
Thomas Dieterle
Publication year - 2012
Publication title -
schweizerische medizinische wochenschrift
Language(s) - English
Resource type - Journals
ISSN - 0036-7672
DOI - 10.4414/smw.2012.13515
Subject(s) - medicine , holy grail , coronary artery disease , secondary prevention , primary prevention , disease , atherosclerotic cardiovascular disease , statin , intensive care medicine , cardiology , world wide web , computer science
In coronary artery disease, cardiovascular risk factors are the main targets for primary and secondary prevention. Statins prevent cardiovascular events in patients at risk. However, despite the proven efficacy and safety of statins, relevant side effects exist and should be considered when treating patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom